MentionFox
Home › Reprise Biomedical, Inc. › team
Company · named in SEC filings

Reprise Biomedical, Inc. founders and team

15 people are named across 7 of Reprise Biomedical, Inc.'s SEC filings, with the role each filing states.

Funding historyFounders and team

What do you want to do with Reprise Biomedical, Inc.?

NameRole stated in the filingNamed in
Carrie PowersExecutive Officer, Director2026-07-01, 2026-05-21, 2025-07-11, 2023-12-13, 2023-11-02, 2023-01-25, 2023-01-03
Erwin KelenDirector2026-07-01, 2026-05-21, 2025-07-11, 2023-12-13, 2023-11-02, 2023-01-25, 2023-01-03
Howard RootDirector, Executive Officer2026-07-01, 2026-05-21, 2025-07-11, 2023-12-13, 2023-11-02, 2023-01-25, 2023-01-03
Phil NalboneDirector2026-07-01, 2026-05-21, 2025-07-11, 2023-12-13, 2023-11-02, 2023-01-25, 2023-01-03
Ronald EibensteinerDirector2026-07-01, 2026-05-21, 2025-07-11, 2023-12-13, 2023-11-02, 2023-01-25, 2023-01-03
Greg SmockExecutive Officer2026-07-01, 2026-05-21, 2025-07-11, 2023-12-13, 2023-11-02
Heather KotilaExecutive Officer2026-07-01, 2026-05-21, 2025-07-11, 2023-12-13, 2023-11-02
Jake IsenburgExecutive Officer2026-07-01, 2026-05-21, 2025-07-11, 2023-12-13, 2023-11-02
Jerrod KruegerExecutive Officer2026-07-01, 2026-05-21, 2025-07-11, 2023-12-13, 2023-11-02
Steve JagodzinskiExecutive Officer2026-07-01, 2026-05-21, 2025-07-11, 2023-12-13, 2023-11-02
Alan WoldtDirector2026-07-01, 2026-05-21, 2025-07-11
Jeff DuncanExecutive Officer2026-07-01, 2026-05-21, 2025-07-11
Tom KouchoukosExecutive Officer2026-07-01, 2026-05-21, 2025-07-11
Phillip NalboneDirector2023-01-25, 2023-01-03
Tina WaltersExecutive Officer2023-12-13, 2023-11-02

Want the whole picture on Reprise Biomedical, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Reprise Biomedical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Reprise Biomedical, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    5 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Names and roles exactly as the filings list them: executive officers, directors and promoters. Nothing here is inferred, and a filing only lists the people it is required to.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Reprise Biomedical, Inc.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/company/reprise-biomedical-inc/team
Last updated 2026-11-09
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Reprise Biomedical, Inc. founders and team (from SEC filings). MentionFox, 2026-11-09. https://mentionfox.com/company/reprise-biomedical-inc/team